Combination Products: US FDA Aims For Limited Two-Application Solutions
Executive Summary
In announcing guidance stating one application generally is sufficient for a combination product, FDA asks for comments on situations where two would be needed.
You may also be interested in...
FDA's Drug Center Permits Some Combo Product Software To Be Submitted As DMFs
New draft guidance from the US agency allows electronics or software that will be used across multiple combination products to be submitted as a Type V drug master file (DMF), potentially streamlining the assessment process.
CDER Permits Some Combo Product Software To Be Submitted As DMFs
New draft guidance allows electronics or software that will be used across multiple combination products to be submitted as a Type V drug master file, potentially streamlining the assessment process.
US FDA's Integrated Review Doc: Industry Says Don't Lose The Detail
Stakeholders, some worried about "groupthink," tell the US FDA they want the individual discipline comments on newly approved drugs to stay in action packages because of the valuable insights they provide.